Prevalence and Cumulative Incidence of Autism Spectrum Disorders and the Patterns of Co-occurring Neurodevelopmental Disorders in a Total Population Sample of 5-year-old Children
Overview
Authors
Affiliations
Backgrounds: Whether there is a true increase in autism spectrum disorder (ASD) frequency or not remains unclear. Additionally, the rates of co-existing neurodevelopmental disorders (NDD) in a total population sample has not been fully examined before. Therefore, using a total population sample in Japan, we aimed to estimate the prevalence and cumulative incidence of autism spectrum disorder (ASD) annually, to determine whether there is a true increase in ASD prevalence by estimating the cumulative incidence of ASD annually, and to examine the rates of co-existing neurodevelopmental disorders (NDD).
Method: In this cross-sectional sequential design study, all 5-year-old children in the catchment area underwent the screening annually from the year 2013-2016. Screen-positive children were invited to participate in a comprehensive assessment, including child and parent interview, behavioral observation, and cognitive and motor function testing. All cases were reviewed by a multidisciplinary research team.
Results: Caregivers of 3954 children returned the screening, among which 559 children underwent the assessment with 87 children receiving an ASD diagnosis. Adjusted ASD prevalence was 3.22% (95% confidence interval (CI) 2.66-3.76%). The male to female ratio of the crude prevalence was 2.2:1. The cumulative incidence of ASD up to 5 years of age for the total study years was 1.31% (95% CI 1.00-1.62%). A generalized linear model revealed no significant linear trends in 5-year cumulative incidence over the study years. Only 11.5% of children had ASD alone; the remaining 88.5% were found to have at least one co-existing NDD.
Limitations: Modest sample size for a total population study.
Conclusions: Our findings demonstrate the stability of the 5-year cumulative incidence of ASD, implying no true rise in ASD incident cases over the 4-year study period in the study catchment area. High rates of co-existing NDDs reflect the importance of investigating broad developmental challenges in children with ASD.
Long D, Yang T, Chen J, Zhang J, Dai Y, Chen L Child Adolesc Psychiatry Ment Health. 2025; 19(1):18.
PMID: 40045319 PMC: 11884192. DOI: 10.1186/s13034-025-00858-9.
Kato Y, Kawahara T, Endo Y, Yamazaki A Jpn J Nurs Sci. 2025; 22(2):e70001.
PMID: 39989006 PMC: 11848237. DOI: 10.1111/jjns.70001.
Co-design of the neurodevelopment assessment scale.
Wong T, Azim S, Lam-Cassettari C, Lin P, Mendoza Diaz A, Montgomery A Front Child Adolesc Psychiatry. 2025; 4:1497632.
PMID: 39944745 PMC: 11811075. DOI: 10.3389/frcha.2025.1497632.
Elandaloussi Y, Dufrenne O, Lefebvre A, Houenou J, Senova S, Laidi C Cerebellum. 2025; 24(2):46.
PMID: 39937336 DOI: 10.1007/s12311-025-01801-6.
Ferrini L, Bartolini E, Mancini A, Tancredi R, Ferrari A, Calderoni S J Clin Med. 2025; 14(2).
PMID: 39860535 PMC: 11766335. DOI: 10.3390/jcm14020529.